HAIs

Latest News


Latest Videos


Shorts

Patty Montgomery, MPH, RN, CIC, FAPIC
0:50
When Gloves Were Considered Insulting to Patients
a year ago
Patty Montgomery, MPH, RN, CIC, FAPIC
1:15
Why 'Gotcha' Moments Don't Work in Health Care
a year ago
Brenna Doran, PhD, MA, who specializes in hospital epidemiology and infection prevention at the University of California, San Francisco, and is a coach and consultant in infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control at Dartmouth Health in Lebanon, New Hampshire; and Shanina C (Dr. Nina) Knighton PhD, RN, CIC, an associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio.
1:23
Burnout, Value, and the Case for Seeing IPs as an Investment
a year ago
by
Tori Whitacre Martonicz, MA
Mark Wiencek, PhD
1:22
Hidden Hazards: Why Hospital Sink Drains Are a Biofilm Breeding Ground
a year ago
by
Tori Whitacre Martonicz, MA
Shannon Simmons, DHSc, MPH, AL-CIP, CIC, MLS (ASCP)
0:52
Unsung Heroes: Elevating EVS as Full Partners in Infection Prevention
a year ago
by
Tori Whitacre Martonicz, MA
Ewan Eadie, PhD, MSci, CSci, MIPEM; and Paul A. Locke, JD, MPH, DrPH, speaking with Tori Whitacre Martonicz, MA.
1:22
Far-UVC: Clean Air for All, Not Just a Privilege
a year ago
by
Tori Whitacre Martonicz, MA


More News

Ebola  (Adobe Stock 71484433 by efks)

The 2026 Ebola outbreak has now spread to the Democratic Republic of Congo and Uganda, with the WHO reporting more than 513 cases and over 130 suspected deaths linked to the Bundibugyo strain, which currently has no approved vaccine or treatment. This article examines the outbreak through both a global health and infection prevention lens, highlighting concerns over weakened public health infrastructure, CDC staffing cuts, reduced USAID funding, and lessons still unlearned from prior Ebola and COVID-19 responses. Experts warn that while widespread US transmission remains unlikely, early investment in global outbreak response is critical to preventing future public health emergencies.

Candida spp, fungi, Close-up micrograph (Adobe Stock 495043092 by MdBabul)

Candida auris continues to challenge infection prevention programs worldwide as cases rise across health care settings and multidrug resistance limits treatment options. In this article, Ayaz Majid, PhD, director of product management at Diasorin, explores why rapid molecular diagnostics are becoming essential tools for identifying colonized patients, supporting isolation protocols, and helping health care facilities prevent outbreaks before they spread.

A sterile processing technician organizing surgical instruments on a table in a clean room environment (Adobe Stock 938500017 By PondLord)

Sterile processing departments are often called the invisible backbone of surgical care, but a recent investigation involving Penn State Health and Milton S. Hershey Medical Center highlights what can happen when those systems come under pressure. Reports of contaminated instrument trays, sterilization backlogs, staffing strain, and communication breakdowns are raising broader questions about patient safety, infection prevention infrastructure, and operational priorities across health care. ***Updated with an answer from Penn State Health.

A depiction of ultraviolet energy as a purple wave on a black background (Adobe Stock 1037776490 by EAStevens)

New evidence suggests UV-C disinfection may do more than reduce pathogens. Repeated exposure can also damage common health care plastics, potentially creating microcracks and roughened surfaces that harbor microorganisms. Experts say material compatibility must become part of every UV-C infection prevention strategy.

IP LifeLine From Infection Control Today

This 6-part series chronicles the journey of 2 infection prevention leaders, Brenna Doran and Jessica Swain, who partnered to research and shed light on the critical issue of IP staffing in the current health care landscape. The fourth article in the series will focus on the impact of geographic variations and staffing models on the support for infection prevention programs.

3D of biofilm on a surface  (Adobe Stock by Christian Heisch)

Peptilogics' PLG0206 represents a breakthrough innovation in infectious disease. First drug designed specifically to penetrate and kill biofilm-protected bacteria. RETAIN Phase 2/3 trial now enrolling patients with prosthetic joint infection. The previous phase showed 93% infection-free rate. It could revolutionize the treatment of medical device-related infections.